Wikidata

(Q62811359)

English

Nocturnal TLA for Severe Allergic Asthma After Withdrawal of Omalizumab Therapy

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
Nocturnal Temperature Controlled Laminar Airflow Device, Airsonett, for Treating Severe Allergic Asthma After Withdrawal of Omalizumab therapyT (English)
0 references
medical condition
asthma
0 references
country
Taiwan
0 references
start time
20 January 2017
0 references
end time
30 November 2018
0 references
number of participants
50
0 references
minimum age
20 year
0 references
maximum age
80 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62811359&oldid=2149408827"